Fulltext

Impact of antiretroviral therapy (ART) timing on chronic immune activation/inflammation and end-organ damage

Rajasuriar R 1 , Wright E , Lewin SR

Affiliations 

  • 1 aCentre of Excellence for Research in AIDS (CERiA) bFaculty of Medicine, Department of Pharmacy, University of Malaya, Kuala Lumpur, Malaysia cDepartment of Infectious Diseases, Alfred Hospital and Monash University dCentre for Biomedical Research, Burnet Institute, Victoria, Melbourne, Australia and Peter Doherty Institute for Infection and Immunity
Curr Opin HIV AIDS, 2015 Jan;10(1):35-42.
PMID: 25415420 DOI: 10.1097/COH.0000000000000118

Abstract

The purpose of this review was to summarize recent studies on the effect of early antiretroviral therapy (ART) in HIV-infected patients on markers of immune activation/inflammation, viral persistence and serious non-AIDS events.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications